+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Hepatitis B Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Nucleoside, Interferon Therapy , Capsid Assembly Modulators, RNA Interference (RNAi) & Antisense Oligonucleotides, Therapeutic Vaccines & Immune Modulators), By Route of Administration (Oral, Parenteral), By Patient Type (Adult Patients, Pediatric Patients), By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies, Online Providers) Companies, and Country Forecast, 2021 to 2034

Global Hepatitis B Therapeutics Market size is forecast to increase from $3 Billion in 2026 to $3.92 Billion in 2034 at a CAGR of 3.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007587
Pages: 219 Pages

Hepatic Fibrosis Biomarkers Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Kits & Reagents, Diagnostic Assays, Testing Services), By Biomarker Type (Direct Biomarkers , Indirect Biomarkers , Biomarker Panels & Algorithms ), By Technology (Immunoassays , Molecular Diagnostics, Proteomics & Metabolomics, Imaging-integrated Biomarkers), By End-User (Diagnostic Laboratories, Hospitals & Specialty Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Hepatic Fibrosis Biomarkers Market size is forecast to increase from $580.66 Million in 2026 to $2319.41 Million in 2034 at a CAGR of 18.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007586
Pages: 217 Pages

Hepatic Encephalopathy (HE) Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Antibiotics , Laxatives & Disaccharides , L-Ornithine L-Aspartate , Ammonia Scavengers , Neuroprotective Agents & Others), By Disease Indication (Acute Liver Failure, Liver Cirrhosis, Portal Systemic Bypass), By Route of Administration (Oral, Intravenous, Rectal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Hepatic Encephalopathy (HE) Therapeutics Market size is forecast to increase from $2.04 Billion in 2026 to $3.58 Billion in 2034 at a CAGR of 7.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007585
Pages: 223 Pages

Heparin Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Low-Molecular-Weight Heparin , Unfractionated Heparin , Ultra-Low-Molecular-Weight Heparin , Synthetic ), By Source (Porcine Mucosa, Bovine Material, Recombinant Microbial Sources), By Dosage Form (Injectable Solutions, Pre-Filled Syringes, Topical Gels & Creams), By Route of Administration (Subcutaneous Injection, Intravenous Infusion), By Application (Venous Thromboembolism , Atrial Fibrillation, Coronary Artery Disease , Renal Impairment & Hemodialysis), By End-User (Hospital Pharmacies & Clinics, Retail & Specialized Pharmacies, Dialysis Centers & Ambulatory Care Facilities) Companies, and Country Forecast, 2021 to 2034

Global Heparin Market size is forecast to increase from $8.36 Billion in 2026 to $10.76 Billion in 2034 at a CAGR of 3.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007584
Pages: 221 Pages

Hemostats Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Passive Hemostats , Active Hemostats , Combination Hemostats), By Formulation (Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats), By Indication (Surgical Hemostasis, Wound Closures), By Application (Orthopedic Surgery, General Surgery, Cardiovascular Surgery, Neurological Surgery, Reconstructive & Plastic Surgery, Trauma and Emergency Care), By End-User (Hospitals & Surgical Suites, Ambulatory Surgical Centers , Tactical Combat & Emergency Care Centers, Specialty Outpatient Clinics) Companies, and Country Forecast, 2021 to 2034

Global Hemostats Market size is forecast to increase from $2.98 Billion in 2026 to $4.93 Billion in 2034 at a CAGR of 6.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007583
Pages: 230 Pages

Hemostats and Tissue Sealants Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Topical Hemostats, Adhesives and Tissue Sealants, Fibrin Sealants), By Composition (Biological-Based, Synthetic-Based, Combination Products), By Application (General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurological Surgery, Trauma Cases), By End-User (Hospitals & Acute Care Systems, Ambulatory Surgical Centers , Specialty Clinics, Research and Academic Institutes) Companies, and Country Forecast, 2021 to 2034

Global Hemostats and Tissue Sealants Market size is forecast to increase from $10.02 Billion in 2026 to $20.11 Billion in 2034 at a CAGR of 9.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007582
Pages: 220 Pages

Hemostatic Instruments Market Size, Share and Growth Outlook, 2026: Analysis By Instrument Type (Hemostatic Forceps , Electrosurgical , Laser Coagulation Systems, Ultrasonic Hemostatic Cutters & Scalpels, Vessel Sealing Devices), By Design Configuration (Straight Hemostatic Instruments, Curved Hemostatic Instruments), By Usage Profile (Reusable Surgical Instruments, Disposable ), By End-User (Hospital Operating Rooms & Surgical Suites, Ambulatory Care & Surgical Centers, Specialized Outpatient Surgical Clinics) Companies, and Country Forecast, 2021 to 2034

Global Hemostatic Instruments Market size is forecast to increase from $6.17 Billion in 2026 to $11.68 Billion in 2034 at a CAGR of 8.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007581
Pages: 210 Pages

Hemostasis Valve Market Size, Share and Growth Outlook, 2026: Analysis By Product Type Configuration (Hemostasis Valve Y-Connectors, Double Y-Connector Valves, One-Handed Hemostasis Valves, Integrated Extension-Line Valves, Push-Pull Hemostasis Valves), By Application Type (Diagnostic Angiography Procedures, Interventional Angioplasty , Endovascular Peripheral Vascular Interventions, Neuro-interventional Procedures, Electrophysiology Studies), By End-User (Hospitals & Cardiac Centers, Catheterization Laboratories , Ambulatory Surgical Centers , Specialty & Outpatient Clinics) Companies, and Country Forecast, 2021 to 2034

Global Hemostasis Valve Market size is forecast to increase from $215.81 Billion in 2026 to $349.19 Billion in 2034 at a CAGR of 6.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007580
Pages: 211 Pages

Hemostasis Products Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Topical Hemostats , Infusible Hemostats , Advanced Hemostats ), By Formulation (Sponges, Gauzes, & Pads, Matrix & Gels, Liquids & Sprays, Powders), By Clinical Application (General & Specialized Surgery , Trauma & Emergency Care, Hemophilia & Clotting Disorder Management, Myocardial Infarction & Thrombosis Treatment), By End-User (Hospitals & Health Systems, Outpatient & Ambulatory Surgical Centers , Military & Emergency First Responders) Companies, and Country Forecast, 2021 to 2034

Global Hemostasis Products Market size is forecast to increase from $2.49 Billion in 2026 to $3.36 Billion in 2034 at a CAGR of 3.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007579
Pages: 212 Pages

Hemostasis Diagnostics Market Size, Share and Growth Outlook, 2026: Analysis By Offering (Diagnostic Systems, Assay Kits, Reagents & Consumables, Maintenance & Quality Control Services), By Application (Bleeding Disorders Diagnosis , Thrombosis & Clotting Disorders, Pre-operative Screening, Anticoagulant Therapy Monitoring), By Test Complexity (Routine Coagulation Tests, Specialty Coagulation Tests , Viscoelastic Testing ), By End-User (Diagnostic Centers, Hospitals, Blood Banks, Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Hemostasis Diagnostics Market size is forecast to increase from $1.47 Billion in 2026 to $2.14 Billion in 2034 at a CAGR of 4.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007578
Pages: 212 Pages